The ₩200 billion autoimmune disease market has finally revealed its form in Korea. The growth of the global leading product ‘Humira’ had fallen somewhat due to the introduction of its biosimilars. The 5 biosimilars by domestic companies Celltrion, Samsung Bioepis, LG Chem, etc. are also increasing their influence in the market, but their total market share remains in the 10% range.

◆ TNF-α inhibitor market shrinks for the first time… aftermath of Humira’s drug price cut

According to the market research institution IQVIA on the 9th, sales in the domestic TNF-α inhibitor market was ₩233 billion, a 0.4% decrease from the previous year.

TNF-α inhibitors